Bolt Biotherapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Redwood City, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Bolt Biotherapeutics, Inc. has filed 291 SEC EDGAR filings since 07 May 2015

SEC filing history

Showing 201-225 of 291 matching filings.

Per page
25
Current page
9
4

FORM 4 SUBMISSION

Filing date
23 Feb 2022
Reporting date
18 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92160

BOLT BIOTHERAPEUTICS, INC.

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Feb 2022
Reporting date
22 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39988

8-K EIRGENIX AMENDMENT

Filing date
25 Jan 2022
Reporting date
25 Jan 2022
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Dec 2021
Reporting date
14 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
16 Dec 2021
Reporting date
14 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39988

8-K NEW DIRECTOR ONETTO

Filing date
16 Dec 2021
Reporting date
13 Dec 2021
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Dec 2021
Reporting date
08 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39988

8-K BDC-1001 INTERIM DATA

Filing date
06 Dec 2021
Reporting date
06 Dec 2021
Next action
Verify source filing
SC 13G File 005-92160

SC 13G filing

Filing date
29 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-92160

SC 13D/A

Filing date
22 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Nov 2021
Reporting date
17 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
19 Nov 2021
Reporting date
17 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Nov 2021
Reporting date
17 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
19 Nov 2021
Reporting date
17 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39988

8-K DIRECTOR APPOINTMENT

Filing date
19 Nov 2021
Reporting date
15 Nov 2021
Next action
Verify source filing
10-Q File 001-39988

Q3 2021 10-Q

Filing date
09 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
8-K File 001-39988

8-K Q3'21 ER

Filing date
09 Nov 2021
Reporting date
09 Nov 2021
Next action
Verify source filing
SC 13D/A File 005-92160

SC 13D/A

Filing date
13 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39988

Q2'21 10-Q

Filing date
12 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
8-K File 001-39988

Q2'21 EPR 8-K

Filing date
12 Aug 2021
Reporting date
12 Aug 2021
Next action
Verify source filing
D File 021-402021

D filing

Filing date
07 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39988

GENMAB AGREEMENT PRESS RELEASE 8-K

Filing date
02 Jun 2021
Reporting date
02 Jun 2021
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .